The project is aimed at establishing a research and development platform for variant specific antibodies against coronavirus infections, especially with a focus on COVID19. Specific COVID19 antibodies will be prepared and tested as part of the project, their effectiveness and harmlessness will be verified on animal models to verify their effectiveness and harmlessness, while minimising the potential risks of adverse reactions for preventive and therapeutic uses against coronavirus infections, with a focus on COVID19